🇺🇸 FDA
Patent

US 8673322

Crystals of laquinimod sodium, and process for the manufacture thereof

granted A61KA61K31/4704A61P

Quick answer

US patent 8673322 (Crystals of laquinimod sodium, and process for the manufacture thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K31/4704, A61P, A61P25/00, A61P29/00